NCT03441958View on ClinicalTrials.gov

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

October 28, 2023

Study Completion Date

October 17, 2025

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

ECT-001 (UM171) expanded cord blood

ECT-001 expanded cord-blood will be produced and infused on site

Trial Locations (1)

H1T2M4

CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond, Montreal

Sponsors
All Listed Sponsors
collaborator

ExCellThera inc.

INDUSTRY

collaborator

Centre C3i

UNKNOWN

lead

Ciusss de L'Est de l'Île de Montréal

OTHER